JPMorgan increases holdings of INNOVENT BIO (01801) by approximately 1,068,900 shares at a price of HK$75.3978 per share.
On June 17th, J.P. Morgan increased its holdings in Sino Biopharmaceutical (01801) by 1,068,875 shares, with a price of HKD 75.3978 per share, for a total amount of approximately HKD 805.08 million.
The latest data from the Hong Kong Stock Exchange shows that on June 17, J.P. Morgan increased its holding of INNOVENT BIO (01801) by 1,068,875 shares, with a price of 75.3978 Hong Kong dollars per share, totaling approximately 805.908 million Hong Kong dollars. After the increase, the latest holding amount is approximately 87.2 million shares, and the latest holding percentage is 5.01%.
Related Articles
Guosen: How do multinational medical device companies view the Chinese market?
HK Stock Market Move | KNOWLEDGE ATLAS (02513) surges more than 13%, entering the global forefront with GLM-5.2. Lyon points to its significant victory in the field of reinforcement learning.
HK Stock Market Move | CATHAY PAC AIR (00293) rose nearly 3% in May, with passenger volume increasing by 17% year-on-year. The company continues to expand its global route network.
Guosen: How do multinational medical device companies view the Chinese market?
HK Stock Market Move | KNOWLEDGE ATLAS (02513) surges more than 13%, entering the global forefront with GLM-5.2. Lyon points to its significant victory in the field of reinforcement learning.
HK Stock Market Move | CATHAY PAC AIR (00293) rose nearly 3% in May, with passenger volume increasing by 17% year-on-year. The company continues to expand its global route network.
RECOMMEND
